Chindex Agrees to Higher $24/Share Bid from Insiders

Chindex, which operates private hospitals and clinics in China, accepted a buy-out offer of $24 per share from company insiders, which values the company at $434 million. The latest offer tops a $23 per share bid by an unnamed suitor, which refused the board’s invitation to raise its offer. The insiders consist of Fosun Pharma, which already owns 17.5% of Chindex, the US private equity group TPG and Roberta Lipson, the company’s founder and CEO. More details.... Stock Symbols: (NSDQ: CHDX) (SHA: 000196; HK: 2196) Share this with colleagues: // //  
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.